The 4S's of Good Giving: Maximizing Your Charitable Donations

November 11, 2016

With the conclusion of 2017 just around the corner, many people will make their annual donations to charitable organizations. Click here to read more.


T1D Board of Directors: It's Time for Change

October 27, 2016

The Board of Directors has more influence on the performance and direction of an organization than anyone else. Click here to read more.


Survey Results: Why We Walk for T1D

October 20, 2016

The JDCA recently completed a polling survey to identify the main reasons people within the T1D community participate in diabetes fundraising walks. Click here to read more.


How the JDRF Uses its Funds

October 13, 2016

The infographic posted above provides a snapshot of how the JDRF, one of the largest and most influential diabetes fundraising organizations, uses its funds. Click here to read more.


Progress Update: Semma Therapeutics

October 11, 2016

Last week, Semma Therapeutics Scientific Co-Founder and Vice President, Felicia Pagliuca, Ph.D., presented a progress report during an industry conference in La Jolla, California, called the Cell and Gene Meeting on the Mesa. Click here to read more.


Practical Cure Project Update: Viacyte

October 7, 2016

Yesterday, the Viacyte CEO, Paul Laikind, presented a progress report during an industry conference in La Jolla, California called the Cell and Gene Meeting on the Mesa. Click here to read more.


How the ADA Uses its Funds

October 5, 2016

The infographic posted above provides a snapshot of how the ADA, one of the largest and most influential diabetes fundraising organisations in the U.S., uses its funds. Click here to read more.


FDA Approves First Closed-Loop Artificial Pancreas

September 29, 2016

FDA approval of a closed-loop artificial pancreas has generated significant press and media coverage during the past 24 hours. Click here to read more.



JDRF and ADA Fundraising Promise Inconsistent with Actual Spending

September 27, 2016

This is the fifth annual review of advertising messages used by the ADA and JDRF at national fundraising events. Click here to read more.


New Documentary Raises Questions About T1D Misdiagnosis

September 22, 2016 

A new documentary that aired on Tuesday evening asserts that T1D is often incorrectly diagnosed. Click here to read more.


2016 Update on Executive Compensation at the Major Type 1 Diabetes Non-Profit Organizations

August 25, 2016

This is the fifth annual review of executive compensation for the top diabetes non-profits. Click here to read more.


Overview of JDRF Research Update Meeting in NYC

August 19, 2016

Last night the JDRF hosted a research update in New York City to discuss key developments in type 1 diabetes research and the organization's areas of focus. Click here to read more.



Update on Type 1 Diabetes Practical Cure Projects Currently in Human Trials

August 11, 2016

This is the fourth annual review of type 1 diabetes human clinical trial research currently underway. Click here to read more.


Research Pathways to a Practical Cure for Type 1 Diabetes

August 3, 2016

This is the first of two reports which will address Practical Cure projects currently in human trials. Click here to read more.



NIH Special Funding Program for Type 1 Diabetes Research Progress Report Summary

July 21, 2016

The United States government has set aside a budget each year since 2008 to support type 1 diabetes research, named the "Special Statutory Funding Program for Type 1 Diabetes Research." Click here to read more.


ADA 2015: 3% of Income Dedicated to T1D Research Grants

July 13, 2016

This is the fourth annual analysis of the ADA's funding for research. The main purpose of reviewing and sharing this data is to help ensure that the T1D community can make informed donation decisions. Click here to read more.


JDRF Research Grant Allocation During 2015

July 1, 2016

This is the fourth annual review of JDRF research grant allocations. The main purpose of reviewing and sharing this data is to help ensure the number one priority of donors—finding a cure for T1D—is being addressed. Click here to read more.



Boston Area Collaboration for a T1D Cure

June 27, 2016

A new and noteworthy collaboration among five Boston-area research centers was announced last week with the goal of finding a cure for T1D. Click here to read more.



Update on the American Diabetes Association's 76th Sessions

June 20, 2016

The American Diabetes Association's 76th Scientific Sessions, the largest diabetes research conference of the year, was held last weekend in New Orleans, Louisiana. Click here to read more.



Update on Diabetes Research Institute's BioHub Initiative

June 3, 2016

This report provides an update on the current status of the Diabetes Research Institute's (DRI) BioHub initiative and chronicles the progression of each of the main research projects, identifying where each stands in the research progression -- laboratory, animal testing, or human trials. Click here to read more.


Islet Cell Transplantation Update: New Phase III Study Results Show Insulin Independence Unchanged

May 19, 2016

New phase III study results on islet cell transplantation were published on April 18. Click here to read more.


New JDRF Board Chairman Must Address Multi-Year Research Decline

April 27, 2016

The JDRF announced that Mark Fischer-Colbrie will be the new Chairman of the JDRF International Board of Directors (IBOD) starting on July 1st of this year. Click here to read more.


Naomi Berrie Research Progress Update: "10 Years to Human Trials"

April 21, 2016

On April 18 the Naomi Berrie Diabetes Center of Columbia University hosted a research update in New York City. Click here to read more.


WHO Releases Inaugural Report on Diabetes
 

April 15, 2016

On April 6th, The World Health Organization (WHO) published its first ever Global Report on Diabetes.  It sets out to provide a comprehensive review of diabetes throughout the world and, as a result, has received a fair bit of recent press. Click here to read more.


Practical Cure Project Update: Perle Bioscience Drug Combination Human Trial "Ends Prematurely"

April 11, 2016

Perle Bioscience, a pharmaceutical company working on diabetes treatments, has ended a Practical Cure research project that was active in human trials. Click here to read more.


JDRF Internal Costs for Administering Research Grants Are the Highest in the Past 15 Years

March 25, 2016

JDRF's cost of administering research grants continues to skyrocket.  During 2015, the internal costs associated with selecting and allocating research grants reached $0.27 per dollar of grant, a 15 year high. Click here to read more.


JDRF Financial Made Simple

March 8, 2016

This report will reveal the key sources of income for JDRF and the primary ways this money was used during 2015. Click here to read more. 


JDRF Releases 2015 Financials: Huge Drop in Research Funding

February 22, 2016

JDRF released their financials and there has been yet ANOTHER major drop in funding. Click here to read more. 


Melton-Anderson Team Publishes New Findings Promising Results in Animals but Still a Long Way to Go Before Testing in Humans

January 28, 2016

Recent study results promising in mice but may still be years away from human trials. Click here to read more.


T1D Donor Community survey: Cure research is #1 priority

January 16, 2016

This is our fourth annual survey-giving report, assessing who gives to type 1 and why. Click here to read more.